Bon Natural Life (BON)
NASDAQ:BON
Want to see BON full AI Analyst Report?
BON Stock Chart & Stats
$1.70
-$0.04(-2.34%)
At close: 4:00 PM EST
$1.70
-$0.04(-2.34%)
Day’s Range― - ―
52-Week Range$1.13 - $3.40
Previous Close$1.67
Volume111.86K
Average Volume (3M)2.24M
Market Cap
$10.16M
Enterprise Value$13.83M
Total Cash (Recent Filing)$6.27M
Total Debt (Recent Filing)$12.32M
Price to Earnings (P/E)―
Beta1.65
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,086,971
10 Day Avg. Volume115,576
30 Day Avg. Volume2,242,045
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.09
Price to Sales (P/S)0.29
P/FCF Ratio-1.27
Enterprise Value/Market Cap1.36
Enterprise Value/Revenue0.74
Enterprise Value/Gross Profit3.56
Enterprise Value/Ebitda630.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Balance-sheet BufferRelatively low leverage and materially higher equity provide a durable cushion against shocks and funding flexibility. With equity expanded over years, the company has balance-sheet capacity to raise capital or absorb losses while it executes restructuring or growth initiatives.
AI-driven Biomanufacturing PartnershipA multiyear R&D and engineering partnership builds a lasting innovation and scale advantage in bio-manufactured natural ingredients. That can sustainably improve unit economics, supply reliability and customer stickiness vs competitors reliant on traditional extraction.
Strengthened R&D LeadershipA formally contracted CTO with deep technical expertise signals renewed emphasis on product and process innovation. Over a multi-year horizon this raises the odds of successful R&D commercialization, improving margins and competitive differentiation in specialty ingredients.
Bears Say
Persistent Negative Free Cash FlowChronic cash burn constrains the company’s ability to self-fund capex, R&D and working capital. Over months this elevates refinancing risk, forces dilution or higher-cost debt, and limits strategic optionality unless operating cash conversion materially improves.
Falling Sales And Margin CompressionDeclining revenue and sharp margin erosion indicate weakening pricing power or rising input costs. This structural deterioration undermines sustainable profitability and raises the bar for any recovery plan, making consistent positive earnings less likely without product or cost fixes.
Rising Leverage And Governance ConcentrationIncreasing debt with thin profits raises refinancing risk, while leadership tied by family relationships may concentrate decision-making and weaken independent oversight. Together these structural risks can amplify execution and capital-allocation mistakes over the medium term.
Bon Natural Life News
BON FAQ
What was Bon Natural Life’s price range in the past 12 months?
Bon Natural Life lowest stock price was $1.13 and its highest was $3.40 in the past 12 months.
What is Bon Natural Life’s market cap?
Bon Natural Life’s market cap is $10.16M.
When is Bon Natural Life’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Bon Natural Life’s earnings last quarter?
Currently, no data Available
Is Bon Natural Life overvalued?
According to Wall Street analysts Bon Natural Life’s price is currently Overvalued.
Does Bon Natural Life pay dividends?
Bon Natural Life does not currently pay dividends.
What is Bon Natural Life’s EPS estimate?
Bon Natural Life’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bon Natural Life have?
Bon Natural Life has 6,086,971 shares outstanding.
What happened to Bon Natural Life’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bon Natural Life?
Currently, no hedge funds are holding shares in BON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bon Natural Life
Bon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.
Technical Analysis
Planet Green Holdings
―
Natural Alternatives International
―
Farmmi
―
Laird Superfood
―
Healthy Choice Wellness Corp. Class A
―